Ph.D. Thesis Award

Dear Colleagues,

The journal Cancers is inviting applications for the Cancers 2024 Best PhD Thesis Award. This prize will be awarded to two PhD students or recently qualified PhDs who have produced a highly anticipated thesis with great academic potential. The applications will be assessed by an evaluation committee led by the Editor-in-Chief, Prof. Dr. Samuel C. Mok.

Eligibility and Requirements

– The candidate must be a PhD student or recently qualified PhD who has produced a highly anticipated thesis with great academic potential;
– The PhD thesis must be their original work;
– The PhD thesis must be defended between 1 June 2023 and 31 May 2024.

Required Application Documents

– An executive summary of the PhD thesis in English of around 3000 words;
– A letter from the PhD supervisor recommending the candidate for consideration for this award;
– The candidate’s CV, including a list of publications connected with the thesis;
– An electronic copy of the PhD thesis;
– A scanned copy of the PhD diploma (or certificate of studying at a school or research institute as a PhD student going to graduate or participate in graduation thesis defenses).

Selection Criteria

– Quality of CV and publications;
– Relevance of the candidate and research description;
– Novelty of the candidate’s PhD thesis;
– Strength of the recommendation letter;
– Anticipated academic potential;
– Originality and impact of the research.

Prizes

– Bonus (CHF 800);
– Certificate;
– Offer to publish one paper free of charge in Cancers after peer review before
the end of July 2025.

The application deadline is 31 May 2024. The winners will be announced on the Cancers website by the end of July 2024.

Cancers Editorial Office

 
Cancers 2024 Ph.D. Thesis Award
 
Application deadline: 31 May 2024
Winner announcement: 31 July 2024
 
Past Winners
 
Year: 

Winner

Gabriele Casirati
Boston Children's Hospital
Roeltje Maas
Université de Lausanne, Switzerland

Award Committee

Dr. Samuel Mok Chairman
UT MD Anderson Cancer Center
Dr. Farrukh Aqil
University of Louisville
Prof. Alexandre Escargueil
Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine
Dr. Shinji Miwa
Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University
Dr. Kevin A. Camphausen
NCI

Winner

João Pedro da Silva Machado Lobo
Instituto Portugues de Oncologia de Francisco Gentil Porto, Porto, Portugal
Adrià Cañellas Socias
IRB Barcelona

Award Committee

Dr. Samuel Mok Chairman
UT MD Anderson Cancer Center
Prof. Craig N. Robson
Newcastle University
Prof. Dr. Dik C. van Gent
Department of Molecular Genetics, Erasmus MC, Univesity Medical Center Rotterdam
Prof. Alexandre Escargueil
Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine
Prof. Brian Gabrielli
Mater Research Institute - The University of Queensland
Dr. Aamir Ahmad
Hamad Medical Corporation
Dr. Ognjen Arandjelovic
University of St Andrews
Prof. Andrea Morrione
Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Department of Biology, Temple University
Prof. Raffaele Capasso
University of Naples Federico II
Prof. Ajay Singh
USA Mitchell Cancer Institute

Winner

Michael Rückert
Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Germany

Award Committee

Dr. Samuel Mok Chairman
UT MD Anderson Cancer Center
Dr. Sharon McKenna
University College Cork
Dr. Marc Poirot
Cancer Research Center of Toulouse, UMR 1037 Inserm-UMR 5071 CNRS, University of Toulouse III
Dr. Sam Mbulaiteye
National Cancer Institute
Dr. Leonhard Müllauer
Medizinische Universität Wien
Prof. Hajime Isomoto
Prof. Dr. Spencer B Gibson
Back to TopTop